SEC Form 4 · accession 0001213900-15-009532
RELMADA THERAPEUTICS, INC. · RLMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shreeram Agharkar
Director
Period of report
Dec 16, 2015
Accepted (ET)
Dec 17, 2015 · 9:35 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001553643
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 16, 2015 | P | 1,000 | $3.45 | A | 5,259 | D | |
| Common stock | Dec 16, 2015 | P | 100 | $3.25 | A | 5,359 | D |
Table II — derivative securities
No Table II lines on this filing.